Charles F Haines1, John A Fleishman, Baligh R Yehia, Bryan Lau, Stephen A Berry, Allison L Agwu, Richard D Moore, Kelly A Gebo. 1. *Department of Medicine, Division of Infectious Disease, The John Hopkins School of Medicine, Baltimore, MD;†Agency for Healthcare Research and Quality (AHRQ);‡University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA;§Department of Epidemiology, The Johns Hopkins University School of Public Health, Baltimore, MD; and‖The Johns Hopkins Department of Pediatrics, Division of Infectious Diseases, Baltimore, MD.
Abstract
BACKGROUND: In the current antiretroviral (ART) era, the evolution of HIV guidelines and emergence of new ART agents might be expected to impact the times to ART initiation and HIV virologic suppression. We sought to determine if times to AI and virologic suppression decreased and if disparities exist by age, race/ethnicity, and HIV risk. METHODS: We performed a retrospective cohort study of data from 12 sites of the HIV Research Network, a consortium of US clinics caring for HIV-infected patients. HIV-infected adults (≥18 year old) newly presenting for care between 2003 and 2013 were included in this study. Times to AI and virologic suppression were defined as time from enrollment to AI and HIV RNA <400 copies per milliliter, respectively. We conducted time-to-event analyses using competing risk regression in the HIV Research Network cohort from 2003 to 2012 in 2-year intervals, with follow-up through 2013. RESULTS: Among 15,272 participants, 76.9% were male, 48.4% black, and 10.9% were injection drug use with median age of 38 years (interquartile range: 29-46 years). The adjusted subdistribution hazards ratios (SHRs) for AI and virologic suppression each increased for years 2007-2008 [SHR 1.23 (1.16-1.30), and SHR 1.25 (1.17-1.34), respectively], 2009-2010 [1.55 (1.46-1.64), and 1.54 (1.43-1.65), respectively], and 2011-2012 [1.94 (1.83-2.07), and 1.73 (1.61-1.86), respectively] compared with 2003-2004. Blacks had a lower probability of AI than whites and Hispanics. CONCLUSIONS: Since 2007, times from enrollment to AI and virologic suppression have decreased significantly compared with 2003-2004, but persisting disparities should be addressed.
BACKGROUND: In the current antiretroviral (ART) era, the evolution of HIV guidelines and emergence of new ART agents might be expected to impact the times to ART initiation and HIV virologic suppression. We sought to determine if times to AI and virologic suppression decreased and if disparities exist by age, race/ethnicity, and HIV risk. METHODS: We performed a retrospective cohort study of data from 12 sites of the HIV Research Network, a consortium of US clinics caring for HIV-infectedpatients. HIV-infected adults (≥18 year old) newly presenting for care between 2003 and 2013 were included in this study. Times to AI and virologic suppression were defined as time from enrollment to AI and HIV RNA <400 copies per milliliter, respectively. We conducted time-to-event analyses using competing risk regression in the HIV Research Network cohort from 2003 to 2012 in 2-year intervals, with follow-up through 2013. RESULTS: Among 15,272 participants, 76.9% were male, 48.4% black, and 10.9% were injection drug use with median age of 38 years (interquartile range: 29-46 years). The adjusted subdistribution hazards ratios (SHRs) for AI and virologic suppression each increased for years 2007-2008 [SHR 1.23 (1.16-1.30), and SHR 1.25 (1.17-1.34), respectively], 2009-2010 [1.55 (1.46-1.64), and 1.54 (1.43-1.65), respectively], and 2011-2012 [1.94 (1.83-2.07), and 1.73 (1.61-1.86), respectively] compared with 2003-2004. Blacks had a lower probability of AI than whites and Hispanics. CONCLUSIONS: Since 2007, times from enrollment to AI and virologic suppression have decreased significantly compared with 2003-2004, but persisting disparities should be addressed.
Authors: John A Fleishman; Kelly A Gebo; Erin D Reilly; Richard Conviser; W Christopher Mathews; P Todd Korthuis; James Hellinger; Richard Rutstein; Philip Keiser; Haya Rubin; Richard D Moore Journal: Med Care Date: 2005-09 Impact factor: 2.983
Authors: Kelly A Gebo; John A Fleishman; Richard Conviser; Erin D Reilly; P Todd Korthuis; Richard D Moore; James Hellinger; Philip Keiser; Haya R Rubin; Lawrence Crane; Fred J Hellinger; W Christopher Mathews Journal: J Acquir Immune Defic Syndr Date: 2005-01-01 Impact factor: 3.731
Authors: Richard M Novak; Rachel L D Hart; Joan S Chmiel; John T Brooks; Kate Buchacz Journal: J Acquir Immune Defic Syndr Date: 2015-09-01 Impact factor: 3.731
Authors: Lauren E Cain; Roger Logan; James M Robins; Jonathan A C Sterne; Caroline Sabin; Loveleen Bansi; Amy Justice; Joseph Goulet; Ard van Sighem; Frank de Wolf; Heiner C Bucher; Viktor von Wyl; Anna Esteve; Jordi Casabona; Julia del Amo; Santiago Moreno; Remonie Seng; Laurence Meyer; Santiago Perez-Hoyos; Roberto Muga; Sara Lodi; Emilie Lanoy; Dominique Costagliola; Miguel A Hernan Journal: Ann Intern Med Date: 2011-04-19 Impact factor: 25.391
Authors: Morgan M Philbin; Daniel J Feaster; Lauren Gooden; Rui Duan; Moupali Das; Petra Jacobs; Gregory M Lucas; D Scott Batey; Ank Nijhawan; Jeffrey M Jacobson; Raul Mandler; Eric Daar; Deborah K McMahon; Wendy S Armstrong; Carlos Del Rio; Lisa R Metsch Journal: Clin Infect Dis Date: 2019-01-01 Impact factor: 9.079
Authors: Jun Li; Elizabeth Humes; Jennifer S Lee; Keri N Althoff; Jonathan A Colasanti; Ronald J Bosch; Michael Horberg; Peter F Rebeiro; Michael J Silverberg; Ank E Nijhawan; Angela Parcesepe; John Gill; Sarita Shah; Heidi Crane; Richard Moore; Raynell Lang; Jennifer Thorne; Timothy Sterling; David B Hanna; Kate Buchacz Journal: Open Forum Infect Dis Date: 2022-07-22 Impact factor: 4.423
Authors: Semiu O Gbadamosi; Mary Jo Trepka; Rahel Dawit; Zoran Bursac; Andrea Raymond; Robert A Ladner; Diana M Sheehan Journal: AIDS Behav Date: 2022-05-10
Authors: Ilex Beltran-Najera; Jennifer L Thompson; Anastasia Matchanova; Kelli L Sullivan; Michelle A Babicz; Steven Paul Woods Journal: Clin Neuropsychol Date: 2021-07-26 Impact factor: 3.535
Authors: Jonathan Colasanti; Jeri Sumitani; C Christina Mehta; Yiran Zhang; Minh Ly Nguyen; Carlos Del Rio; Wendy S Armstrong Journal: Open Forum Infect Dis Date: 2018-06-28 Impact factor: 3.835
Authors: Robert Freeman; Marya Gwadz; Leo Wilton; Linda M Collins; Caroline Dorsen; Robert L Hawkins; Elizabeth Silverman; Belkis Y Martinez; Noelle R Leonard; Amanda Applegate; Sabrina Cluesman Journal: Int J Equity Health Date: 2020-08-28